Keenova Therapeutics plc Secured Debt
Keenova Therapeutics plc had Secured Debt of $3.75 billion as of 2025-09-26, per its 10-Q filed 2025-11-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:SecuredDebt · last filed 2025-11-10
- 2025-09-26: Secured Debt $3.75B.
- 2024-12-27: Secured Debt $915.60M.
- 2023-09-29: Secured Debt $3.89B.
- 2022-04-01: Secured Debt $3.48B.
| Period end | Secured Debt |
|---|---|
| 2025-09-26 | $3.75B 10-Q · filed 2025-11-10 |
| 2024-12-27 | $915.60M 10-Q · filed 2025-11-10 |
| 2023-09-29 | $3.89B 10-Q · filed 2023-11-07 |
| 2022-04-01 | $3.48B 10-Q · filed 2022-05-03 |
| 2021-12-31 | $3.49B 10-Q · filed 2022-05-03 |
| 2021-09-24 | $3.49B 10-Q · filed 2021-11-02 |
| 2021-06-25 | $3.50B 10-Q · filed 2021-08-03 |
| 2021-03-26 | $3.50B 10-Q · filed 2021-05-04 |
| 2020-12-25 | $3.62B 10-K · filed 2022-03-15 |
| 2019-12-27 | $3.15B 10-K · filed 2021-03-10 |